GoodRx shares are pulling back Tuesday morning. The stock had jumped over 30% Monday after the company announced a new ...

We recently published 12 Best Healthcare Stocks to Buy Under $30. GoodRx Holdings, Inc. (NASDAQ:GDRX) is one of the best ...

GoodRx stock soars after announcing GLP-1 partnership with Novo Nordisk. A Bank of America analyst recommends selling GDRX ...

What Happened? Shares of healthcare tech company GoodRx (NASDAQ:GDRX) jumped 40.2% in the afternoon session after the company ...

GoodRx and Novo Nordisk launch a $499 monthly self-pay option for Ozempic and Wegovy, expanding access at 70,000 pharmacies ...

The healthcare company will offer the GLP-1s for $499 a month, the lowest-ever out-of-pocket cost for the weight-loss ...

GoodRx (Nasdaq: GDRX) has teamed up with Novo Nordisk (NOV: N) to make all dose levels of Ozempic (semaglutide) and Wegovy ...

GoodRx Announces Date for Fourth Quarter and Full Year 2024 Earnings Release and Conference Call SANTA MONICA, Calif., January 30, 2025--GoodRx Holdings, Inc. (Nasdaq: GDRX) ("GoodRx" or the "Company" ...

In a report released today, Jailendra Singh from Truist Financial maintained a Hold rating on GoodRx Holdings (GDRX – Research Report), with a price target of $6.50. The company’s shares ...

One stock to keep an eye on is GoodRx (GDRX). GDRX is currently holding a Zacks Rank of #2 (Buy) and a Value grade of A. The stock has a Forward P/E ratio of 10.11.

GoodRx Holdings Inc (NASDAQ:GDRX) is set to release its Q2 2025 earnings on Aug 6, 2025. The consensus estimate for Q2 2025 ...

Read More on GDRX: GoodRx sees FY24 revenue at ‘low end’ of $800M-$810M, consensus $806.38M GoodRx sees Q3 revenue $193M-$197M, consensus $202.37M GoodRx reports Q2 adjusted EPS 8c, consensus 9c ...